| 词条 | AMB-CHMINACA |
| 释义 |
| IUPAC_name = methyl (2S)-2[1-(cyclohexylmethyl)indazole-3-carbonyl]amino3-methylbutanoate | image = AMB-CHMINACA.svg | tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = Schedule II | legal_UK = | legal_US = | legal_status = | routes_of_administration = | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number_Ref = (racemate) | CAS_number = 1863066-03-8 | ATC_prefix = | ATC_suffix = | PubChem = 119026010 | ChemSpiderID = 32055578 | UNII = OU56JJP891 | smiles = COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O | StdInChI = 1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1 | StdInChIKey = CRGGXDSTBHQLKJ-SFHVURJKSA-N | C=21 | H=29 | N=3 | O=3 | molecular_weight = 371.5 g/mol }}AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.[2][3][4] Legal statusAMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5] See also{{div col|colwidth=30em}}
References1. ^{{cite journal|last1=Akamatsu|first1=Shigeki|last2=Yoshida|first2=Masashi|title=Fragmentation of synthetic cannabinoids with an isopropyl group or a tert-butyl group ionized by electron impact and electrospray|journal=Journal of Mass Spectrometry|date=January 2016|volume=51|issue=1|pages=28–32|doi=10.1002/jms.3722|pmid=26757069}} {{Cannabinoids}}{{cannabinoid-stub}}2. ^{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/16421 | title=MA-CHMINACA | publisher=Cayman Chemical | accessdate=21 July 2015}} 3. ^{{cite web | url=http://forendex.southernforensic.org/index.php/detail/index/1301 | title=MA-CHMINACA | publisher=Southern Association of Forensic Scientists | accessdate=21 July 2015}} 4. ^{{cite journal | author1=Samuel D Banister|display-authors=et al | url=http://pubs.acs.org/doi/abs/10.1021/acschemneuro.5b00112 | title=The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues | date=July 2016 | journal=ACS Chemical Neuroscience | doi=10.1021/acschemneuro.6b00137 | pmid=27421060 | volume=7 | issue=9 | pages=1241–54}} 5. ^{{cite web | url=http://www.cnb.gov.sg/Libraries/CNB_Newsroom_Files/CNB_NR_-_30_Apr_2015.sflb.ashx | title=CNB NEWS RELEASE | publisher=Central Narcotics Bureau (CNB) | date=30 April 2015 | accessdate=21 July 2015}} 4 : Cannabinoids|Designer drugs|Indazoles|Indazolecarboxamides |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。